Trial intelligence / Profile preview

Phase II trial of collagenase ointment for diabetic foot ulcer

CTR20251247Phase 2Completed

Sponsor
Grand Life Sciences
Start
May 2025
Modality
Therapeutic Enzymes → Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of collagenase clostridium histolyticum in diabetic foot ulcer (DFU), sponsored by Grand Life Sciences. Started May 2025; status: completed.

02

Drugs

collagenase clostridium histolyticum
03

Conditions

diabetic foot ulcer (DFU)

Beyond the preview

Go deeper on CTR20251247.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20251247.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call